We’re an award-winning, patient-centered biotechnology company focused on using the body’s own microorganisms to prevent and treat debilitating infections and diseases.
Location: United Kingdom
Employees: 11-50
Total raised: $83.47M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Investing ... | investingw... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 02.06.2026 | - | $25.73M | - |
| 05.04.2024 | - | $34.22M | - |
| 07.09.2021 | Series A | $21M | - |
| 29.05.2019 | Seed | $2.53M | - |
Mentions in press and media 21
| Date | Title | Description |
| 20.08.2026 | Bacteria, Billions and Buzzwords: Is the Gut Microbiome Startup Boom Backed by Science? | Investors have bankrolled hundreds of millions of pounds into companies that claim they can decode the inner workings of your gut. Behind the personalised nutrition apps and at-home stool tests, as well as the pitch deck for the next genera... |
| 02.06.2026 | DIGIT Deal Roundup | May 2026 | Welcome to May 2026’s DIGIT Deal Roundup. Some major deals sent shock waves through the Scottish tech ecosystem this month. From local AI startups joining the fold of one of the world’s biggest players to some major acquisitions. Beyond tha... |
| 10.05.2026 | EnteroBiotix Secures $25M for Landmark IBS Drug Trial | EnteroBiotix, a Scottish biotech firm, secured £19 million ($25M) to advance its IBS drug, EBX-102-02. This significant investment fuels a Phase 2b clinical trial targeting irritable bowel syndrome, a widespread condition. The company's inn... |
| 04.05.2026 | Opaque Acquires Cryptographic AI Technology from Abu Dhabi-Based Technology Innovation Institute | Opaque, a San Francisco, California-based Confidential AI company, acquired advanced cryptographic AI technologies from the Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Counc... |
| 04.05.2026 | EnteroBiotix secures £19M to support IBS microbiome clinical trial | Glasgow-based life sciences company EnteroBiotix has secured £19 million in funding to support the advancement of its microbiome-based therapies, including a large-scale clinical trial targeting irritable bowel syndrome (IBS). The round was... |
| 04.05.2026 | EnteroBiotix Raises £19M in Funding | EnteroBiotix Limited, a Glasgow, Scotland, UK-based biopharmaceutical company developing microbiome therapies for gut health, raised £19m ($25m) in funding. The round was led by Thairm Bio and the Scottish National Investment Bank, with par... |
| 04.05.2026 | Glasgow Biotech EnteroBiotix Raises £19m for IBS Drug Trial | Glasgow-headquartered life sciences scaleup EnteroBiotix has completed a £19 million investment, one of the largest investments into a Scottish biotech company in recent years, to support one of the world’s most extensive clinical trials of... |
| 12.12.2025 | Biotech Boost to Bring 460 New Jobs to Grangemouth | Up to 460 new biotech jobs are expected to be created in Grangemouth as part of an £8.5 million support package announced by the Scottish Government, following the closure of Scotland’s only crude oil refinery earlier this year. Edinburgh-b... |
| 23.07.2025 | Global Investors Zero In on Scottish Startups | Scottish startups are gaining global attention, according to a new report, with early-stage funding attracting a host of new international investors into the country’s innovation market. The latest Scotland Newcomer Investors Report from st... |
| 10.12.2024 | The Biggest Scottish Tech Deals of 2024 | Despite strong economic headwinds, a hostile investment environment, geopolitical tensions and….. 2024 has – against all odds – been a strong year for Scotland’s tech, life sciences, and business sectors, marked by transformative acquisitio... |
Show more